Wednesday, 26 August 2026European Markets

AMG Stock Over 13% Down So Far On Thursday

Loading stream...

Amsterdam-based AMG (AEX-Index: AMG.AS) is currently experiencing significant market fluctuations. On Thursday, shares dropped an alarming 13.36% at 11:07 EST to reach EUR40.78. This noticeably poor performance happened amid otherwise buoyant trading sessions where the AEX-Index gained 1.58% and reached EUR787.73.

Previous Market Trend

Continuing its previous downward trend, AMG's closing price dropped 5.84% since last session to EUR47.07 - 5.884% below its 52-week high of EUR49.99.

About AMG Critical Materials N.V.

AMG Critical Materials N.V. is an international multi-national corporation engaged in the production and sale of engineered specialty metals and mineral products. It caters to a variety of markets, including but not limited to, transportation, infrastructure, energy production and supply, and specialty metals and chemicals. The company operates globally through three segments with primary operations in countries such as the US, China, Germany, and Brazil among others.

Financial Performance

AMG achieved an earnings per share (EPS) of EUR6.27 in its trailing twelve month earnings period, thus yielding considerable profits. However, recent market fluctuations have significantly reduced share value. The company's price-to-earnings ratio stands at 6.5, indicating that investors have low expectations or believe in a decelerating growth potential of AMG.

Return on Equity

AMG's return on equity, calculated by dividing net income by shareholders' equity, stands at an impressive 46.59% over the past twelve months. This is despite it stock price slump and indicates strong management practices as well as good returns for its investors.

More news about AMG (AMG.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com